A forum for healthcare practitioners with an interest in medicinal cannabis

  • Home
  • WELCOME
  • Who we are
  • Join Us
  • Teach-Hub
  • Guidance
  • COMPASS
  • Contact Us
  • Meeting recordings
  • SCCAC Opinion
  • UIC Symposium 2023
  • INTERNATIONAL PAIN SURVEY
  • Clinical Papers/Articles
    • Anxiety
    • Chronic pain
    • Cancer related syptoms
    • Chronic conditions
    • Cannabinoid Hyperemesis
    • Controversies
    • Driving
    • Endometriosis
    • Fibromyalgia
    • General
    • Geriatrics
    • Mental Health
    • Neurology
    • Opioid usage
    • Parkinson's disease
    • Prescribing
    • Real World Evidence
    • Safety
  • Alerts
  • More
    • Home
    • WELCOME
    • Who we are
    • Join Us
    • Teach-Hub
    • Guidance
    • COMPASS
    • Contact Us
    • Meeting recordings
    • SCCAC Opinion
    • UIC Symposium 2023
    • INTERNATIONAL PAIN SURVEY
    • Clinical Papers/Articles
      • Anxiety
      • Chronic pain
      • Cancer related syptoms
      • Chronic conditions
      • Cannabinoid Hyperemesis
      • Controversies
      • Driving
      • Endometriosis
      • Fibromyalgia
      • General
      • Geriatrics
      • Mental Health
      • Neurology
      • Opioid usage
      • Parkinson's disease
      • Prescribing
      • Real World Evidence
      • Safety
    • Alerts
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • WELCOME
  • Who we are
  • Join Us
  • Teach-Hub
  • Guidance
  • COMPASS
  • Contact Us
  • Meeting recordings
  • SCCAC Opinion
  • UIC Symposium 2023
  • INTERNATIONAL PAIN SURVEY
  • Clinical Papers/Articles
    • Anxiety
    • Chronic pain
    • Cancer related syptoms
    • Chronic conditions
    • Cannabinoid Hyperemesis
    • Controversies
    • Driving
    • Endometriosis
    • Fibromyalgia
    • General
    • Geriatrics
    • Mental Health
    • Neurology
    • Opioid usage
    • Parkinson's disease
    • Prescribing
    • Real World Evidence
    • Safety
  • Alerts

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

compass - our national compassionate access scheme

COMPASS is our national medicinal cannabis compassionate access scheme. Following a pilot, we are delighted to announce that this scheme is now open for prescribers to apply for compassionate access for any patient unable to afford their supply.


You can watch the launch meeting video (to the left), or view the updated presentation as a PDF (below) to better understand the scheme. 


Prescribers (only) may apply for individual patient access by clicking here. Patients may not apply themselves.

PDF Viewer

Download PDF

Options available through COMPASS

100% free

100% free + $10 flat postage free

100% free + $10 flat postage free

For the most in-need patients, full support with zero cost. All stakeholders contribute their services for free, including dispensing and courier costs.

100% free + $10 flat postage free

100% free + $10 flat postage free

100% free + $10 flat postage free

 Postage Fee: For patients highly in need, but able to contribute thepostage fee. Full support with only the postage fee as cost to the patient. 

$40 per unit

100% free + $10 flat postage free

$40 per unit

 Patients pay a flat $40 per unit for their medicines. This cost covers $25 for the pharmacy's dispensing fee and$15 for the distributor's courier costs. 

PARTICIPATING BRANDS

DONATING COMPANIES

The Australian Medicinal Cannabis Association and its healthcare practitioner association, Cannabis Clinicians Australia would like to acknowledge and thank the above companies who have generously donated products to the COMPASS compassionate access scheme.